We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. ORLANDO — In this video from the American Academy of ...

UNICORE SOLUTIONS PRIVATE LIMITED is a Private Limited Company, governed by the Companies Act as a company limited by shares. Classified as a Non-government company, it is registered under the ...

On 29 October, at Fiumicino and Malpensa airports, a first group of 71 refugee students arrived, winners of scholarships offered by 33 Italian universities as part of the seventh edition of the ...

Delight for Felix Rosenqvist and despair for David Malukas as final lap heroics brought the smallest winning margin in history at the 2026 Indy 500 Mercedes was the dominant force in Canada, and there ...

Just as Adverum Biotechnologies' cash reserves were running dry, Eli Lilly has swooped in to buy the biotech and its phase 3-stage eye disease gene therapy. The prize for Lilly is ixo-vec, an ...

Screening closing ahead of expectations, with full enrollment now anticipated in 4Q 2025 (previously 1Q 2026) ARTEMIS topline data readout accelerated to 1Q 2027 REDWOOD CITY, Calif., Sept. 22, 2025 ...

This product is open source! Various bits of the code have different licenses applied. Anything SparkFun wrote is beerware; if you see me (or any other SparkFun employee) at the local, and you've ...

Bunker Holding subsidiary Unicore Fuel Europe has hired a regional manager for Europe. Robin van Elderen has joined the company as regional manager for Europe, based in Rotterdam, as of this month, he ...

Ixo-vec utilizes a proprietary vector capsid, AAV.7m8, carrying an aflibercept coding sequence under the control of a proprietary expression cassette and is designed to be administered as a one-time ...

Ixo-vec is a potential best-in-class one-time gene therapy designed to deliver long-term efficacy, reduce the burden of frequent anti-VEGF and improve vision outcomes for patients with wet AMD ARTEMIS ...